LarvolClinCancer Trial Results
Trials Conferences Kaplan-Meier Plot Forest Plot Influencers
menu
Back

SUONET 2017 - 18th Annual Meeting of the Society of Urologic Oncology

Nov 28 - Dec 02, 2017 | Washington, DCUS

LARVOL is not affiliated with 18th Annual Meeting of the Society of Urologic Oncology and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 5 abstracts linked to Trials

A PHASE 3 TRIAL TO COMPARE EFFICACY AND SAFETY OF LENVATINIB IN COMBINATION WITH EVEROLIMUS OR PEMBROLIZUMAB VS SUNITINIB ALONE IN FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

  • CLEAR
    Poster

KEYNOTE-564: PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PEMBROLIZUMAB AS ADJUVANT TREATMENT FOR RENAL CELL CARCINOMA

  • KEYNOTE-564
    Poster

SURVIVAL OUTCOMES FOR AFRICAN-AMERICAN (AA) VERSUS MATCHED CAUCASIAN (CAU) PATIENTS WITH METASTATIC CASTRATE-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH SIPULEUCEL-T.

  • Poster

SURVIVAL OUTCOMES FOR AFRICAN-AMERICAN (AA) VERSUS MATCHED CAUCASIAN (CAU) PATIENTS WITH METASTATIC CASTRATE-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH SIPULEUCEL-T.

  • Poster

KEYNOTE-564: PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PEMBROLIZUMAB AS ADJUVANT TREATMENT FOR RENAL CELL CARCINOMA

  • Poster

Copyright © LARVOL 2023. All rights reserved.

  • Privacy Policy
  • Terms of Service
clear

Trials

Conferences

Kaplan-Meier Plot

Forest Plot

Influencers

Feedback

Privacy Policy Terms of Service